Xutao Guo, Yunxia Zhang, Xiaolei Wei, Haohao Lei, Qi Wei, Yongqiang Wei, Dongsheng Wu, Ning Su, Ru Feng. "A Phase II study of time-limited treatment with orelabrutinib plus bendamustine and obinutuzumab (OBG) in patients with treatment-Naïve CLL/SLL patients." Blood, 2025. doi:10.1182/blood-2025-7417